85 related articles for article (PubMed ID: 21029689)
1. [Gene therapy based on inducible IL-12 gene in a mouse model of orthotopically transplanted H22 hepatoma].
Li YR; Zhang HY; Jin ZJ; Li YL; Wang L
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):487-91. PubMed ID: 21029689
[TBL] [Abstract][Full Text] [Related]
2. [Construction of recombinant plasmid pIRES-GM-CSF-IL-21 and its therapeutic effect on orthotopically transplanted liver cancer in mice].
Cheng MR; Li Q; Hong XW; Ye T; He B; Cheng ZJ; Xu HZ; Zha BB
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):661-5. PubMed ID: 22340045
[TBL] [Abstract][Full Text] [Related]
3. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
Wang J; Zhang CQ; Liu J; Sui LH
Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
[TBL] [Abstract][Full Text] [Related]
4. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome].
Wang KM; Xia AD; Chen SS
Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639
[TBL] [Abstract][Full Text] [Related]
5. Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer.
Zabala M; Lasarte JJ; Perret C; Sola J; Berraondo P; Alfaro M; Larrea E; Prieto J; Kramer MG
J Hepatol; 2007 Dec; 47(6):807-15. PubMed ID: 17935823
[TBL] [Abstract][Full Text] [Related]
6. Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma.
Wang Z; Qiu SJ; Ye SL; Tang ZY; Xiao X
Cancer Gene Ther; 2001 Oct; 8(10):751-8. PubMed ID: 11687898
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma.
Hu P; Hu HD; Chen M; Peng ML; Tang L; Tang KF; Matsui M; Belladonna ML; Yoshimoto T; Zhang DZ; Xiang R; Ren H
Mol Immunol; 2009 May; 46(8-9):1654-62. PubMed ID: 19299021
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice.
Kayashima H; Toshima T; Okano S; Taketomi A; Harada N; Yamashita Y; Tomita Y; Shirabe K; Maehara Y
J Immunol; 2010 Jul; 185(1):698-708. PubMed ID: 20498356
[TBL] [Abstract][Full Text] [Related]
9. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
Guo C; Liu QG; Yang W; Yao YM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
[TBL] [Abstract][Full Text] [Related]
10. [Combined gene therapy for murine liver cancer with interleukin-18 and cytosine deaminase genes].
Sun W; Tang Z; Wei D; Tang Y; Chen S
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):300-2. PubMed ID: 11676879
[TBL] [Abstract][Full Text] [Related]
11. Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition.
Sun HX; He HW; Zhang SH; Liu TG; Ren KH; He QY; Shao RG
Cancer Gene Ther; 2009 Sep; 16(9):693-702. PubMed ID: 19247395
[TBL] [Abstract][Full Text] [Related]
12. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
[TBL] [Abstract][Full Text] [Related]
13. [The inhibitory effect of recombinant polypeptide CH50 of fibronectin on invasion and angiogenesis of tumors].
Yu ZR; Zhang GM; Li D; Liu Y; Geng H; Xiao H; Wu FH; Feng ZH
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):815-9. PubMed ID: 17416001
[TBL] [Abstract][Full Text] [Related]
14. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
16. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
[TBL] [Abstract][Full Text] [Related]
17. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Torimura T; Ueno T; Kin M; Taniguchi E; Nakamura T; Inoue K; Sakata R; Hashimoto O; Sakamoto M; Ohira H; Kumashiro R; Sata M; Yano H; Kojiro M; Veitonmaki N; Cao Y
Gastroenterology; 2006 Apr; 130(4):1301-10. PubMed ID: 16618420
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine.
Lü HZ; Wu DZ; Wan YL; Gu B; Gao HZ; Liang YQ; Wang JX
Zhongguo Yao Li Xue Bao; 1999 May; 20(5):440-4. PubMed ID: 10678093
[TBL] [Abstract][Full Text] [Related]
20. [Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model].
Yamashita Y
Fukuoka Igaku Zasshi; 2002 Aug; 93(8):135-40. PubMed ID: 12382412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
